Literature DB >> 9448668

Antipsychotic agents and bipolar disorder.

M Tohen1, C A Zarate.   

Abstract

Antipsychotic agents have been used commonly in the treatment of bipolar disorder. This article reviews the evolution of the use of antipsychotic agents and their role in the acute and maintenance treatment of bipolar disorder. The focus is on neuroleptic drugs, the atypical antipsychotic drugs (risperidone and clozapine), and two fo the new atypical antipsychotic drugs that were recently approved.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9448668

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN： 0160-6689            Impact factor:   4.384


  6 in total

Review 1.  Functional impairment and cognition in bipolar disorder.

Authors:  C A Zarate; M Tohen; M Land; S Cavanagh
Journal:  Psychiatr Q       Date:  2000

Review 2.  Olanzapine: a review of its use in the treatment of bipolar I disorder.

Authors:  N Bhana; C M Perry
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

3.  Treatments for chronic psychosis.

Authors:  C A Tamminga; A C Lahti
Journal:  Dialogues Clin Neurosci       Date:  2001-12       Impact factor: 5.986

4.  Optimal duration of risperidone or olanzapine adjunctive therapy to mood stabilizer following remission of a manic episode: A CANMAT randomized double-blind trial.

Authors:  L N Yatham; S Beaulieu; A Schaffer; M Kauer-Sant'Anna; F Kapczinski; B Lafer; V Sharma; S V Parikh; A Daigneault; H Qian; D J Bond; P H Silverstone; N Walji; R Milev; P Baruch; A da Cunha; J Quevedo; R Dias; M Kunz; L T Young; R W Lam; H Wong
Journal:  Mol Psychiatry       Date:  2015-10-13       Impact factor: 15.992

5.  Ritanserin as an adjunct to lithium and haloperidol for the treatment of medication-naive patients with acute mania: a double blind and placebo controlled trial.

Authors:  Shahin Akhondzadeh; Hassan Mohajari; Mohammad Reza Mohammadi; Homayoun Amini
Journal:  BMC Psychiatry       Date:  2003-06-19       Impact factor: 3.630

6.  Efficacy and safety of brand-risperidone versus similar-risperidone in elderly patients with neuropsychiatric disorders: A retrospective study.

Authors:  Jefferson Cunha Folquitto; Sérgio Barbosa de Barros; Jony Arrais Pinto Junior; Cássio M C Bottino
Journal:  Dement Neuropsychol       Date:  2010 Jan-Mar
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.